CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 150 filers reported holding CASTLE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,361,081 | +61.2% | 80,585 | +30.9% | 0.01% | +75.0% |
| Q2 2023 | $844,397 | -11.9% | 61,545 | +45.9% | 0.00% | -20.0% |
| Q1 2023 | $958,375 | +44.7% | 42,182 | +49.9% | 0.01% | +25.0% |
| Q4 2022 | $662,510 | +10.1% | 28,144 | +21.9% | 0.00% | 0.0% |
| Q3 2022 | $602,000 | +41.0% | 23,091 | +18.6% | 0.00% | +33.3% |
| Q2 2022 | $427,000 | – | 19,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |